Font Size: a A A
Keyword [Dual Antiplatelet Therapy]
Result: 21 - 40 | Page: 2 of 5
21. SC99 Inhibits Platelet Aggregation Via Syk/STAT3/PLC?2 Signaling Pathway
22. The Effect Estimate Of Antiplatelet Agents Plus Statins Therapy On The Recurrence And Progress Of TIA/Minor Stroke During Hospitalization
23. The Analysis Of Risk Factors And The Outcomes Of Dual Antiplatelet Therapy On The CISS Type Of Acute Minor Stroke
24. Correlation Of Cytochrome P450 2C19 Gene Polymorphism And Risk Of Gastrointestinal Bleeding (GIB) In Coronary Heart Disease (CHD) Patients On Dual Antiplatelet Therapy After Percutaneous Coronary Interventions (PCI)
25. Comparing The Clinical Outcomes In Patients With Atrial Fibrillation Receiving Dual Antiplatelet Therapy And Patients Receiving An Addition Of An Anticoagulant After Coronary Stent Implantation:A Systematic Review And Meta-analysis
26. Association Of In-stent Restenosis With Patient Compliance After Drug-eluting Stent
27. Meta-analysis Of Trials Comparing The Safety Of Dual Antiplatelet Therapy Versus Triple Antithrombotic Therapy In Patients With Atrial Fibrillation After PCI
28. The Safety Study Of No Stop Using Dual Antiplatelet Therapy (DAPT) Treatment In Patients With Coronary Artery Disease Undergoing Off-pump Coronary Artery Bypass Grafting (OPCABG)
29. A Randomized,Parallel-controlled Study Of Dual Antiplatelet Therapy And Aspirin Monotherapy In The Treatment Of Mild To Moderate Acute Non-cardiogenic Ischemic Stroke
30. Effects Of Different Antiplatelet Aggregation Regimens On Acute Ischemic Stroke And The Prognostic Factors:A Retrospective Analysis
31. Effect Of Preoperative Continued Dual Antiplatelet Therapy On Early Outcomes In Patients Undergoing Off-pump Coronary Artery Bypass Grafting
32. Study On The Application Of Gene And Platelet Function Detection For Individualized Dual Antiplatelet Therapy
33. Effects Of Prolonged Dual Antiplatelet Therapy (>12 Months) On The Progonosis Of Patients With Acute Coronary Syndrome
34. Effects Of Different P2Y12 Inhibitors In Patients With Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
35. Influence Of Proton Pump Inhibitors On Clinical Outcomes In Coronary Heart Disease Patients Receiving Dual Antiplatelet Therapy: A Meta-analysis
36. Correlation Between Platelet Function Test And Dual Antiplatelet Therapy In Patients With Non-ST-segment Elevation Acute Coronary Syndrome
37. The Optimal Duration Of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
38. Correlation Analysis On Dual Antiplatelet Therapy Combined Gastrointestinal Bleeding In Acute Coronary Syndrome Patients Undergoing Coronary Stent Implantation
39. Long-term Efficacy And Safety Of Novel Biodegradable Polymer–coated Cobalt-chromium Sirolimus-eluting Stents In Patients With Coronary Artery Disease 4 Year Clinical Outcomes Of The I-LOVE-IT 2 Trial
40. Safety And Efficacy Of Long-term Dual Antiplatelet Therapy In Patients With Complex Coronary Artery Disease Treated With Percutaneous Coronary Intervention
  <<First  <Prev  Next>  Last>>  Jump to